Dr. Alan C. Dejarnatt, MD

Dr. Dejarnatt practices at Family Allergy & Asthma in Louisville, Kentucky.

Dr. Dejarnatt's NPI, 1598750184, was assigned on September 20, 2005. Dr. Dejarnatt graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1986. Dr. Dejarnatt holds Tennessee license 19924.

Dr. Dejarnatt's primary practice is Family Allergy & Asthma, at 9800 Shelbyville Rd, Louisville, KY 40223 in Jefferson County. The practice phone is (502) 429-8585.

Dr. Dejarnatt's primary practice is Family Allergy & Asthma in Louisville, Kentucky. Dr. Dejarnatt is also affiliated with West Tennessee Healthcare Jackson-Madison County General Hospital. The medical group on file is Family Allergy & Asthma. Dmand AI also links Dr. Dejarnatt to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dejarnatt practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Dejarnatt's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Dejarnatt is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Dejarnatt's licenses on file in 2 states: Tennessee and Texas.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis, hives and immune deficiency disease among the conditions Dr. Dejarnatt treats.

CMS data shows 16,371 Medicare services from Dr. Dejarnatt across 15 procedure codes in 2024, for 288 Medicare patients. Medicare paid $333,723 for them. Every service was in an office.

CMS counts 288 Medicare patients who saw Dr. Dejarnatt in 2024. The largest group is 65 to 74, with 164 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 5% are also on Medicaid. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dejarnatt's median patient age at 46, with 57% women.

In 2024, Dr. Dejarnatt wrote 1,240 Medicare Part D claims for 256 patients. 70% of them were for generic drugs. CMS names the drug for 1,091 of them, across 25 drugs with 11 or more claims each, at $1,198,372 in total drug cost. In 2023, CMS named 1,056 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Dejarnatt for performance year 2024, reported as part of a group. Dr. Dejarnatt accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Dejarnatt. The most frequent topics are Skin Tests. Dr. Dejarnatt's most frequent co-author is John Andrew Grant, MD.

CMS Open Payments shows 492 general payments to Dr. Dejarnatt from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,023.

Dr. Dejarnatt graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1986. Dr. Dejarnatt is a member of AAAAI.

Dr. Dejarnatt is in network with 11 carriers, including Aetna, Elevance and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.